The First National Brain and Health Technology Industry Conference (B30 Conference) was successfully concluded in Shenzhen Guangming Science City
Guangdong Science and Technology News (reporter Liu Xiaoyong) From October 26 to 27, the first national brain and health technology industry conference (hereinafter referred to as "B30" conference) was successfully concluded in Shenzhen Guangming District, Shenzhen Chinese Academy of Sciences Shenzhen University of Science and Technology (tentative name, referred to as "Shenzhen Polytechnic") Pearl Campus. The conference gathered the industry leaders of "science and technology + capital + industry", and conducted a comprehensive discussion on the cutting-edge technology and industrial development status, future trend and industrial ecological construction in the fields of brain science, brain technology, brain health, brain intelligence, brain disease and brain rehabilitation technology.
The conference was hosted by Shenzhen Municipal Development and Reform Commission, Shenzhen Municipal Science and Technology Innovation Commission, Shenzhen Guangming District People's Government, Shenzhen University of Science and Technology of the Chinese Academy of Sciences (preparing), Shenzhen Institute of Advanced Technology of the Chinese Academy of Sciences, co-hosted by the Shenzhen-Hong Kong Institute of Brain Science and Innovation, Shenzhen Deep Brain Kang Technology Co., Ltd., Neuroscience Research And Technology Branch of the Chinese Neuroscience Society, and co-organized by the Synaptic and Plasticity Professional Committee of the Chinese Society of Neuroscience and the Autonomous Neurological Professional Committee of the Chinese Physiological Society.
Yao Gaoke, member of the Standing Committee of the Guangming District Committee and candidate for deputy district governor, and Fan Jianping, director of the Preparatory Office of Shenzhen University of Science and Technology of the Chinese Academy of Sciences and president of the Shenzhen Institute of Advanced Technology of the Chinese Academy of Sciences (hereinafter referred to as "Shenzhen Advanced Institute"), attended the conference and delivered speeches. Relevant leaders of Guangdong Provincial Science and Technology Department, Shenzhen Municipal Development and Reform Commission, Shenzhen Municipal Science and Technology Innovation Commission, and Shenzhen Guangming District attended the event.
The B30 conference attracted nearly 300 people to participate offline, and the number of online live broadcast viewers (two days cumulative) exceeded more than 1.4 million (Shenzhen Business Daily live broadcast platform information), which has received widespread attention from all walks of life.
An action of the times: The Bright Brain Science and Technology Industry Innovation Center officially landed in Guangming
As the source of innovation and innovation service platform of the brain and health industry, the Bright Brain Science and Technology Industry Innovation Center (hereinafter referred to as the "Brain Innovation Center") built by the Institute of Brain Cognition and Brain Diseases of Shenzhen Advanced Institute (hereinafter referred to as the "Brain Institute") was officially unveiled at the meeting. "Brain Innovation Center" is jointly built by the Guangming District Government and Shenzhen Advanced Institute, with a total investment of more than 100 million yuan and an incubation space of more than 10,000 square meters. With the starting point of "the demand side is out of the question, the science and technology community answers the question", the Brain Innovation Center builds the country's first common technical service platform for the brain science industry around the key pain points of the industrial transformation in the field of brain science and brain-like intelligence, bases itself on the Greater Bay Area and radiates the whole country, and creates an industrial development ecology of "laying eggs + aggregation effect along the way".
In order to fully support the development of brain and health industry technology, the conference carried out the signing ceremony of "Guangming Science City Brain and Brain-like Intelligent Industrial Park", according to the work deployment, it will cooperate with China Merchants to build Guangming Brain and Brain-like Intelligent Industrial Park (China Merchants Base) in Guangming to support the development of the start-up technology team in the Brain Innovation Center in the middle and late stages. In addition, in order to introduce the first-class technical teams in the field of mental health at home and abroad to Shenzhen to introduce the bright landing, and to cultivate a number of unicorn enterprises with industry benchmarking effect for the mental health industry in the future, the "Yitou Mental Health Technology Laboratory" cooperated by the Shenzhen Advanced Institute brain institute and the Yitou Plan was also unveiled at the B30 conference.
A collision of ideas: big coffee talks about the brain and the new future of the health industry
In order to clarify the logic of industrial development and explore a new incubation system, the conference invited well-known science and technology entrepreneurs, investment institutional investors, and academicians and experts from the American Academy of Arts and Sciences and the Royal Canadian Academy of Sciences. They deeply focus on the frontiers of brain science, and output core value points around the six major areas of "sleep industry economy, mental mental health, brain-computer fusion intelligence, new drug research and development of encephalopathy, early diagnosis and treatment of encephalopathy, and gene therapy technology", providing insights for the rapid development of the brain and health industry.
Gong Hongjia, a well-known technology entrepreneur and well-known investor, said, "China is gradually entering a deeply aging society. Frontier breakthroughs in the fields of brain science, brain health, brain intelligence, brain rehabilitation, brain diseases and other fields are brewing huge industrial changes; It will also play an important role in promoting the future application of new technologies for early diagnosis and treatment of brain diseases and rehabilitation, and new technologies for brain-computer integration. The Guangming B30 Brain and Health Technology Industry Conference gathered a group of many domestic investment institutions, brain scientists, clinicians, seeing everyone's enthusiasm, but also felt that the investment outlet in this field is coming. I am very much looking forward to growing with this field. ”
As a representative of experts and scholars, Feng Guoping, an academician of the American Academy of Arts and Sciences, brought a keynote speech "Advancing Precision Medicine to Mental Health", he shared, "Brain diseases are one of the most burdened diseases in humans, and the emergence of technologies such as genome sequencing, gene editing, single-cell sequencing and optogenetics has a very important role in promoting the research of brain diseases and the development of drugs." Now is the best time to invest in brain diseases, and although it is early on, there are many mechanism studies of brain diseases that can be translated into therapeutic targets and approaches to drug development. ”
Wang Yutian, a member of the Royal Canadian Academy of Sciences, delivered a keynote speech entitled "Bench to Bed - Can We Cross the Valley of Death?". He offers his own insights on how to cross the "basic to clinical" divide in brain science: "One is to build a research team of scientists and doctors; the other is to find the right reliable target; the third is to choose the best drug; and the fourth is to conduct the right clinical design experiment." ”
Zhu Xun, honorary chairman of the Tongyi New Drug Talents Club, said: "The field of brain disease treatment has broad prospects, but the success rate is very low. Mainly because the pathogenesis is very complex, there is no conclusion, the design of clinical protocols is more difficult, with new research progress and technical means, this field will certainly have a more rapid development. ”
As a strategic partner of this conference, Fosun Chuangfu, which is deeply rooted in the great health track, will develop together with the industry and investment integrated with the brain, and accelerate the transformation of scientific research achievements.
Chen Xin, Co-President of Fosun Chuangfu and President of Fosun Guangdong-Hong Kong-Macao Greater Bay Area Equity Investment and Financing Division, said at the conference, "Fosun Chuangfu regularly tracks the progress of a large number of start-up enterprises and taps the excellent sub-tracks of the present and future through Fosun's strong global industrial system and its layout in the advantageous industries of medical and health care.
From another point of view, Fosun's industrial characteristics are around the three core demands of health, happiness and wealth, to create an industrial ecology that runs through the whole life cycle of the family, to achieve such a goal, brain science, brain disease rehabilitation, brain health including mental health is essential, Fosun will increase its attention to this field in the future!
The Fosun Wealth Creation team with industrial background can better grasp the needs of enterprises, realize the business synergy and upstream and downstream cooperation between invested enterprises and Fosun system, and also have the ability to actively industrialize scientific research results, cutting-edge technologies and high-growth projects with the help of practical experience of past international investment. We will maintain close communication with the Shenzhen Advanced Institute, including the Institute of Brain Science and Innovation of Shenzhen and Hong Kong, and hope that there will be very good cooperation opportunities in production, learning, research and capital in the future. ”
As a long-term observer of the development of the brain and health industry, Huang Li, a founding partner of the well-known investment institution Tongchuang Weiye, said, "From the perspective of the current situation of the whole society, it is urgent to develop brain science to the brain industry, thereby reducing the medical burden and improving human welfare. Along this core path, we will focus on the three major areas of understanding the brain, protecting the brain, and simulating the brain, and look forward to connecting with more innovative scientists, doctors and entrepreneurs in the first time to promote the rapid development of the brain and health industry. ”
Sharing investment partner Huang Instead pointed out in his keynote speech "New Trends in Medical and Health Investment under Two-Wheel Drive": "Medical investment can usually be summarized into four major logics: precision medicine, import substitution, scientific and technological progress, and consumption upgrading. In the future, precision medicine and consumption upgrading will bring greater opportunities.
The core of precision medicine is the common development of various bioomics, focusing more on innovative technologies and products; and consumption upgrading has spawned a variety of emerging medical services, driven by three new: new populations, new needs, and new scenarios.
An important part of the investment strategy is how to choose the segmentation field, because the medical track is very broad, there are thousands of kinds of instruments alone, if we invest everything, it seems that the investment is medical, but the middle may lack a main line of penetration, resulting in a god-like shape. The field of combining brain science with the health industry is a new blue ocean of investment that deserves close attention."
Ma Rui, a partner at FreesFund Fengrui Capital, made an interpretation of the brain science industry, "The investment in brain science and technology is at the right time: first, the aging is very serious; second, the progress of cutting-edge biotechnology provides new tools; third, brain and cognitive neuroscience has reached a turning point. In the next 5-10 years, new tools for brain science research will bring new targets, new ways of treating brain diseases, and more accurate analytical diagnostic methods, which are the biggest opportunities in the future. ”
During the conference, academic experts in the field of brain science, investors in well-known domestic investment institutions, and experts in neurosurgery and psychiatry from well-known medical institutions in China conducted three roundtable forums with the themes of "Brain Science and Brain Industry - Scientists and Entrepreneurs Talk About the Future of the Brain", "'In-depth Production, Education and Research' to Build the World's Leading Brain Science Research Base", "'Clinical• Scientific Research and Transformation' Focus on Clinical Problems in Brain Science and Discuss the New Trend of Global Industrial Development", respectively, and conducted three roundtable forums to analyze the current development trend of brain science in an in-depth and simple way. Deeply focus on the pain points of the industry, from the perspective of "production-learning-research-use-capital" integration, discuss how to transfer the source technology to the market, so as to solve the problems of the clinical market and the people's demands, and talk about the new future of the brain and the health industry.
When talking about how capital can promote scientific and technological progress, Fu Wenbo, general manager of IDG Innovation Investment Research Institute, has a deep understanding: "IDG Capital can be said to be a very early and long-term supporter and companion in the field of brain science in China. As early as ten years ago, we began to support the frontier basic research of brain science in Tsinghua, Peking University and Beijing Normal University through public welfare donations. Brain science has always been regarded as the 'ultimate frontier' for human understanding of natural phenomena and themselves, and its "basic research" promotion often requires great patience, and it is the fundamental basis for the combination of production, education and research to withstand loneliness in a long cycle of investment. This coincides with IDG Capital's insistence on creating long-term social value. In the future, we will continue to help the development of basic research in brain science through public welfare and other forms. We are also honored to witness the dawn of its gradual transformation and application from basic research to engineering, and will also support and explore more industry-university-research fields. ”
Wang Ning, vice president of the First Affiliated Hospital of Fujian Medical University, explained how to do original innovation from the perspective of doctors doing research, "Among the more than 7,000 genetic rare diseases, more than 4,000 are related to the nervous system. As clinicians who focus on inheriting rare diseases, we have many examples of new gene loci discovered by comparing rare populations and cohort populations, which are important objects of drug development, and gene therapy drugs developed based on these loci often receive good results in the treatment of major diseases. Doctors, scientists and investors work together to do it, which is a very good way to seize the commanding heights at present, and Shenzhen should be the best environment for domestic investment. ”
Zhuo Min, an academician of the Royal Canadian Academy of Sciences, said that the two-day conference fully demonstrated the "bright" future of brain and health technology, and the roadshow of industrialization projects such as EEG analysis, digital diagnosis and treatment of brain diseases, brain-computer fusion technology and new drug research and development was brilliant, hoping that more original research results in brain science and far-sighted investors could form a gathering and collide sparks.
According to statistics, the conference released a total of 15 invited reports, held 3 roundtable forums, and made a comprehensive interpretation of the various industrial chains of brain and health from different perspectives.
A form of innovation: "face-to-face communication" between 30 investment institutions and 30 innovative projects
"B30 Conference" is the first time in the field of brain and health in China to be a grand scale, wide coverage, science and technology, industry and capital circles, the degree of participation is very high, aiming to focus on the Shenzhen Municipal Development and Reform Commission, Guangming District Government jointly supported by the "Bright Brain Science and Technology Industry Innovation Center" as the focus, in-depth exploration of the creation of "Science-Hub-Ventures" in Guangming Science City all-round incubation system, that is, "science + resource sharing + capital" deep integration, innovation, entrepreneurship, Venture capital "three innovations in one" new model of scientific and technological innovation integration and development.
Standing at this foothold, the conference invited and attracted (in alphabetical order): Bairong Capital, Mint Angel Fund, Poly Capital, Beifeng Capital, Country Garden Venture Capital, Danlu Capital, Desong Capital, Oriental Fuhai, Sharing Investment, FreesFund Fengrui Capital, Furong Investment, Fosun Chuangfu, Hi-Tech Xinjun, Hillhouse Capital, Co-construction Venture Capital, Guangtian Group, Guangzhou Fuxin Venture Capital Co., Ltd., SDIC Investment Management Co., Ltd., Nuclear Capital, Honghui Capital, Sequoia Capital, Hongtai Fund, Huachuang Capital, BGI Gene-Miracle Light Venture Capital Fund, Huagai Southern Investment Management (Shenzhen) Co., Ltd., Huaxing Capital, IDG Innovation Investment Research Institute, Jiayin Fund Pharmaceutical, Kefa Capital, Quark Capital, Lanxi Capital, Lanchi Venture Capital, Blue Ocean Capital, Rongtao Capital, Shangyi Investment, Shanghai Hanggui Investment Management Co., Ltd., Shenzhen Innovation Investment Group Co., Ltd., Shenzhen High-tech Investment Zhengxuan Equity Investment Fund Management Co., Ltd., Shenzhen Guangming District Guidance Fund Investment Management Co., Ltd., Shenzhen Haifutong Venture Capital Co., Ltd., Shenzhen Lihe Venture Capital Co., Ltd., Shenzhen Angel Fund of Funds, Shenzhen Angel Investment Guidance Fund Management Co., Ltd., Sheng Qu Capital, TEDA Investment, Tomson By-Health, Taomen Venture Capital, Tibei Capital, Tianchao Capital, Tongchuang Weiye, Wanwu materials, Weishi Capital, Wuyuan Capital, Xian Pupil Capital, Xingze Capital, Yucheng Investment, Yuansheng Venture Capital, Zhilin Capital, Zhongke Science and Technology Achievement Transformation Equity Investment Fund, CIC Zhongcai Fund, CITIC Securities, CITIC Capital, Purple Bull Fund, including 63 well-known domestic investment institutions, and with the 30 selected high-tech enterprises or innovative technology teams in the field of brain science, brain technology, brain health, brain intelligence, brain disease and brain rehabilitation technology to conduct "face-to-face exchanges" to jointly explore the future of industrialization.
Wang Liping, director of the Institute of Brain Research, president of the Shenzhen-Hong Kong Brain Science Innovation Research Institute, and head of the organizational team of the B30 Conference, said, "The national medical burden caused by various brain diseases is increasing, and the rise and increasingly wide application of artificial intelligence and big data technology are looking forward to the source breakthrough in the field of brain science, brain technology, brain intelligence, brain health, brain disease and brain rehabilitation. The complexity of the brain determines that the industrial team with the core technology in this field needs the continuous support of the professional brain science and technology team and the platform to minimize the probability of falling into the "valley of death", accelerate the iteration cycle of technology and products, and maximize the innovation-driven development. The layout of future industrial development will gradually rely more on teams with source innovation capabilities and carriers that share technology and equipment. The Bright Brain Science and Technology Industry Innovation Center is positioned in the establishment of the Science Hub Ventures system and mechanism to strengthen the innovation momentum of "innovation, entrepreneurship, venture capital, three innovations in one, and integrated development". The Shenzhen Guangming B30 Brain and Health Technology Industry Conference gathered more than 60 domestic head capital and industrial technology teams in the field of brain industry in many cities across the country. In the future, B30 Conference will strive to build a new model of "science and technology + innovation resource sharing + capital" in the fields of brain science and technology, life and health, intelligent technology and other fields, integrate symbiosis, serve the independent innovation and development of national science and technology, and serve the new era of China's new economic development! ”